Dear Reader :

This month’s edition of Pharma Intelligence’s newsletter, developed in alliance with the IPA, spotlights distinct shifts and action in the clinical trials arena.

We take a deep dive into how the Asia-Pacific region has emerged as a trial hotspot over the past decade; notably, India led the way for COVID-19 treatment trials, though China was tops with most vaccine trial starts. The trials segment also continues to attract big US retailers – we have a piece on latest entrant Walmart.

There’s also a fascinating write-up on how artificial intelligence is beginning to transform biologics drug discovery. 2021 saw 30 deals between pharma companies and AI-native biologics firms.

Anju Ghangurde - Executive Editor (Asia Pacific), Scrip/Pink Sheet
Dr. Shridhar Narayanan - Senior Technical Advisor - Innovation, IPA


alt_text Perspective from Industry Leaders
Vid Desai On How US FDA’s Modernization Will Improve Inspections And Drug Review alt_text
US FDA’s New Acting Generics Chief Relearning System After 24 Years Of Experience Pfizer R&D Chief Mikael Dolsten Reflects On The COVID-19 Pandemic Experience

In the first part of an exclusive two-part interview, Samsung Bioepis’ development division leader Kyung-Ah Kim...
 

I still remember how I screamed 'oh my god, it's just unbelievable,'" worldwide president R&D Mikael Dolsten told Scrip.
 
alt_text LICENSING & COLLABORATION AGREEMENTS
alt_text alt_text
MPP Strikes Landmark Licensing Deal With Novartis On Nilotinib Deal Watch: OrsoBio Reveals Its Metabolic Health Focus With Four Licensing Pacts

The Medicines Patent Pool has struck a milestone voluntary licensing deal with new partner Novartis for nilotinib to treat chronic myeloid leukemia.

California biotech also notes prior licensing deal with Gilead for mitochondrial candidate. Twentyeight-Seven acquires RNA-splicing cancer candidate from Basilea.
alt_text NEXT GEN: R&D
alt_text Kabi Brings In Reddy’s Rituximab As Biosimilar Breakeven Date Retreats
AI In Biologics Discovery: An Emerging Frontier Sparta Breaks Through With Synthetic Cartilage To Address Osteoarthritis

AI is beginning to transform biologics discovery. The power of algorithms used in biologics discovery has increased over the last decade, and today between 50 and 60 AI-enabled biologics are in different stages...
 

Sparta Biomedical is developing a synthetic cartilage-on-titanium knee implant based on its proprietary Galene process for infusing cellulose fibers with polyvinyl alcohol.
 
alt_text CLINICAL TRIALS
alt_text alt_text
APAC As A Clinical Trial Powerhouse Trials In Focus: Walmart Joins Growing List Of Retailers Entering Clinical Research

In the last 10 years, APAC has become a hotspot for clinical trials: the region contributed almost 50% of new clinical trial activity globally in 2021.
 

SIGA provides an update on its monkeypox program, while Massive Bio announces progress on its AI platform for connecting cancer patients to trials...
 
Citeline Contact

Poornachandra Tejasvi .K, Senior Director - Emerging Markets, India

Direct: +91 11143155159
Mobile: +91 9945273146
Email: poornachandra.tejasvi@informa.com
Client Services: clientservices@pharmaintel.informa.com
 
IPA Contact

Direct: +91 022 2610 9281
Email: info@ipa-india.org
alt_text alt_text alt_text